Stellar Biotechnologies Inc. (SBOT)

1.025 +0.0301 (+3.025%)

IEX Real-Time Price

10:40:18 AM EST.

NASDAQ Capital Market : Healthcare

Prev Close 0.9949

Price Open 1.01

Volume: 3,123

Avg Volume: 62,193

Market Cap: 5.46M

P/E Ratio -0.48

52 Wk Range 0.95-8.7087



SBOT Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
4.75M
226,301
3.15
4.76%

2018-09-28
4.75M
249,782
0.96
5.26%

2018-09-14
4.75M
230,297
0.94
4.85%

2018-08-31
4.75M
159,014
2.95
3.35%




SBOT Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-08
Q3 2018
N/A
-0.45 (1)
-0.38
0.07

2018-07-03
Q2 2018
N/A
0.00 (0)
0.00
0.00

2018-02-07
Q1 2018
N/A
-0.14 (1)
-0.13
0.01

2017-12-01
Q4 2017
N/A
-0.14 (1)
-0.12
0.02

News

Stellar Biotechnologies to Present at BlueTech Summit (2018-10-31 07:30 PR Newswire)

LOS ANGELES , Oct. 31, 2018 /PRNewswire/ --Stellar Biotechnologies, Inc. (Nasdaq: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy and immuno-oncology development pipelines, announced today that Stellar President and CEO Frank R. Oakes will present…

 


Statistics

Shares Outstanding: 5.33M

Top 15 Institution Percent: 0.70

Price To Sales: 33.32

Price To Book: 0.43

Revenue: 20487

Gross Profit: -80364

Cash: 5.37M

Debt: N/A

Return On Assets: -47.02

Return On Equity: -48.90

Profit Margin: N/A

Price History

Beta: -0.03

50-day Moving Avg: 1.25

200-day Moving Avg: 2.86

YTD Change: -83.30

5-day Change: -5.25

1-month Change: -16.39

3-month Change: -26.30

6-month Change: -52.85

1-year Change: -87.37

Revenue Per Share: 0.00

Revenue Per Employee: 732.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Stellar Biotechnologies Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.stellarbiotechnologies.com

Stellar Biotechnologies Inc is a biotechnology company engaged in the aquaculture, research and development, manufacture and commercialization of Keyhole Limpet Hemocyanin (KLH) protein.